跳至主要内容
临床试验/NCT02001857
NCT02001857已完成4 期

Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.

University Hospital, Ghent1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
200
试验地点
1
主要终点
time between operation and first flatus, first peristalsis, first passing of stool and removal of gastrostomy tube (signs of ileus recuperation).

研究概览

简要总结

Pelvic lymph node dissection (PLND) is the most accurate staging tool to determine lymph node involvement in prostate and bladder cancer. The main complication of PLND is development of a lymphocele, which can cause symptoms including lower abdominal pain, leg or penile/scrotal edema, bladder outlet obstruction, deep venous thrombosis or infection/sepsis. The incidence of radiographic (asymptomatic) and symptomatic lymphoceles following PLND varies between 12,6-63% and 1,6-33% respectively. Medicated sponges such as Tachosil® are indicated in surgery for improvement of haemostasis and to promote tissue sealing. They could reduce lymphocele development by increased tissue sealing, due to a mechanical effect of the sponge itself and a lymphostatic effect of the included thrombin and fibrinogen. Our goal is to prospectively assess the lymphostatic effect of Tachosil(r) in patients undergoing transperitoneal PLND with or without radical prostatectomy or PLND with bladder cancer surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old
  • Diagnosis of prostate cancer or bladder cancer on pathology
  • Undergoing transperitoneal pelvic lymph node dissection.

排除标准

  • Previous pelvic surgery or irradiation.
  • Any type of clotting disorder.

研究组 & 干预措施

TachoSil

Experimental

TachoSil

干预措施: 1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery. (Drug)

结局指标

主要结局

time between operation and first flatus, first peristalsis, first passing of stool and removal of gastrostomy tube (signs of ileus recuperation).

时间窗: Daily during standard postoperative care up to date of first flatus, first peristalsis, first passing of stool and removal of gastrostomy tube (signs of ileus recuperation), with an expected average of 1 day.

specific for bladder cancer

development of a radiographic lymphocele on abdominal ultrasonography

时间窗: at week 4 post-surgery

volume of radiographic lymphoceles

时间窗: at week 4 post-surgery

duration of postoperative drainage catheter

时间窗: Daily during standard postoperative care until removal of the catheter, with an expected average of 1 day.

volume produced by postoperative drainage catheter (lymphorrhea)

时间窗: Daily during standard postoperative care until removal of the drain, with an expected average of 1 day.

次要结局

  • decrease in serum hemoglobin on the first postoperative day(at week 4 post-surgery)
  • development of a symptomatic lymphocele.(at week 4 post-surgery)
  • duration of hospital stay(at week 4 post-surgery)
  • total cost(at week 4 post-surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Effect of TachoSil® on Incidence of Symptomatic and... | 临床试验